Olaparib in Patients With BRCA Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer

Professor Jonathan Ledermann (UCL Cancer Institute) said: "These are encouraging results for patients with ovarian cancer who carry a BRCA mutation. Read: Press Release More: Wall Street Journal (no link)